Bioventus (BVS) Acquisitions (2021 - 2022)
Bioventus' (BVS) quarterly Acquisitions came in at $104.6 million in Q4 2022, up 328.46% YoY from $24.4 million in Q4 2021, and up 2092300.0% on a QoQ basis from -$5000.0 in Q3 2022.
Bioventus (BVS) Acquisitions (2021 - 2022) Analysis & Trends
Bioventus (BVS) has 2 years of Acquisitions data on file, last reported at $104.6 million in Q4 2022.
- Quarterly Acquisitions rose 328.46% year-over-year to $104.6 million in Q4 2022, while the trailing twelve-month figure through Oct 2022 was $367.7 million (changed N/A YoY) and the FY2021 annual result came in at $262.9 million, changed N/A from the prior year.
- Acquisitions climbed to $104.6 million in Q4 2022, from -$5000.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $262.9 million in Q4 2021 to a low of -$45.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 1, 2022 | 104.61 Mn |
| Jul 2, 2022 | -5,000.00 |
| Apr 2, 2022 | 236,000.00 |
| Dec 31, 2021 | 262.87 Mn |
| Oct 2, 2021 | -45.79 Mn |
| Jul 3, 2021 | -1,000.00 |
| Apr 3, 2021 | 45.79 Mn |